European registry of babies born to mothers with antiphospholipid syndrome: A result update

Lupus

Volumn 18, Issue 10, 2009, Pages 900-904

  Boffa, Marie Claire ^a,h   Lachassinne, E ^b   Boinot, C ^c   De Carolis, S ^d   Rovere Querini, P ^e   Avcin, T ^f   Biasini Rebaioli, C ^g   Le Toumelin, P ^b   Aurousseau, M H ^a   Tincani, A ^g  

^a Laboratoire d'Hématologie   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d CATHOLIC UNIVERSITY   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^g UNIVERSITY OF BRESCIA   (Italy)

^h HÔPITAL JEAN VERDIER   (France)

Author keywords

Abnormal neuropsychological development; Anti beta; 2 glycoprotein 1 antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Newborn; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; APGAR SCORE; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; COHORT ANALYSIS; EUROPE; FEMALE; FETUS DEATH; FETUS WASTAGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MOTHER; NEUROPSYCHOLOGICAL TEST; NEWBORN DEATH; PREECLAMPSIA; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; REGISTER; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE;

ANTIPHOSPHOLIPID SYNDROME; EUROPE; FEMALE; HUMANS; INFANT, NEWBORN; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 68949175634     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309106951     Document Type: Article

References (29)

1. Soulier JP Boffa MC. Avortements à repetition, thromboses et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980; 9: 859-864.
2. Cervera R Piette JC Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027.
3. Cervera R Khamashta MA Shoenfeld Y Camps MT Jacobsen S Kiss E. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: A multicenter prospective study of 1,000 patients. Ann Rheum Dis 2008 (in press).
4. Heilman L Schorch M Hahn T Adasz G Schilberz K Adiguzel C. Pregnancy Outcome in women with antiphospholipid antibodies: Report on a retrospective study. Semin Thromb Hemost 2008; 34: 794-802.
5. Laskin CA Spitzer KA Crowther MR et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the Randomized, controlled HepASA Trial. J Rheumatol 2009; 36: 279-287.
6. Botet F Romera G Montagut P Figueras J Carmona F Balasch J. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997; 25: 192-196.
7. Ruffatti A Tonello M Cavazzana A Bagatella P Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009; 123: 482-487.
8. Tincani A Bazzani C Zingarelli S Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: Clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost 2008; 34: 267-273.
9. Brewster JA Shaw NJ Farquharson RG. Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999; 27: 183-187.
10. Ruffatti A Tonello M Del Ross T et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006; 96: 337-341.
11. Boffa MC Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: A review. Lupus 2007; 16: 634-641.
12. Pollard JK Scott JR Branch DW. Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome. Obstet Gynecol 1992; 80: 365-368.
13. Ruffatti A Dalla Barba B Del Ross T et al. Outcome of fifty-five newborns of antiphospholipidantibody-positive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 1998; 16: 605-610.
14. Boffa MC Aurousseau MH Lachassinne E et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004; 13: 713-717.
15. Wilson WA Gharavi AE Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
16. Miyakis S Lockshin MD Atsumi T et al. International consensus statement on an update of the classificat ion criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
17. Brandt JT Triplett DA Alving B et al. Criteria for the diagnosis of lupus anticoagulants an update. Thromb Haemost 1995; 74: 1185-1190.
18. Galli M Reber G De Moerloose P de Groot PG. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008; 6: 399-401.
19. Boffa MC Bionot C De Carolis S et al. Laboratory criteria of the obstetrical antiphospholipid syndrome (APS). Data from a multicentric prospective European women cohort. Thromb Haemost 2009; 102: 25-28.
20. Nacinovich R Galli J Bomba M et al. Neuropsycological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008; 59: 345-351.
21. McAllister DL. KaPLan, BJ, Edworthy, SM, et al. The influence of systemic lupus erythematosus on fetal development: Cognitive, behavioral, and health trends. J Int Neuropsychol Soc 1997; 3: 370-376.
22. Ross G Sammaritano L Nass R Lockshin M. Effects of mothers' autoimmune diseases during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003; 157: 397-402.
23. Neri F Chimini L Bonomi F et al. Neuropsycho-logical development of children born to patients with systemic lupus erythematosus. Lupus 2004; 13: 805-811.
24. Tincani A Rebaioli CB Andreoli L Lojacono A Motta M. Neonatal effects of maternal antiphospholipid syndrome. Curr Rheumatol Rep 2009; 11: 70-76.
25. el-Roeiy A Gleicher N Isenberg D Kennedy RC Shoenfeld Y. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus. Clin Exp Immunol 1987; 68: 528-534.
26. Zurgil N Bakimer R Tincani A et al. Detection of anti-phospholipid and anti-DNA antibodies andtheir idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus 1993; 2: 233-237.
27. 2-glycoprotein1 antibodies in healthy new-born cord sera. Thromb Haemost 2008; 99: 1124-1126.
28. 2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: A follow-up study. Am J Perinatol 2006; 23: 247-251.
29. 2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology (Oxford) 2001; 40: 565-573.